Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Open-label, 96-week Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection.

NCT00335322 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT00335322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Open-label, 96-week Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection.
Lead sponsor
Kirby Institute
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2007
Completion date
November 30, 2011
Enrollment
329 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)